Since 1997, we have been constantly working to ensure that patients in our country have direct access to branded, innovative pharmaceutical products.
GENESIS' Pharma portfolio includes novel branded pharmaceutical products of high therapeutic value, many of which are biotech.
Most of these pharmaceutical products are intended exclusively for hospital use, and are designed to meet therapeutic needs of patients with rare and serious diseases.
HEMATOLOGY
ICLUSIG® (Ponatinib)
|
Incyte Biosciences Distribution B.V. |
MINJUVI® (Tafasitamab)
|
Incyte Biosciences Distribution B.V.
|
POTELIGEO® (Mogamulizumab)
|
Kyowa Kirin Holdings B.V.
|
| VYXEOS® LIPOSOMAL (Daunorubicin/Cytarabine) |
Jazz Pharmaceuticals Ireland Ltd. |
| |
|
ONCOLOGY
| LIBTAYO® (Cemiplimab) |
Regeneron Ireland Designated Activity Company (DAC) |
PEMAZYRE® (Pemigatinib)
|
Incyte Biosciences Distribution B.V. |
|
TUKYSA® (Tucatinib)
|
Pfizer Europe MA EEIG
|
|
YONDELIS® (Trabectedin)
|
PharmaMar SA
|
CENTRAL NERVOUS SYSTEM
|
AVONEX® (Interferon Beta-1a)
|
Biogen Netherlands B.V.
|
|
FAMPYRA® (Fampridine)
|
Biogen Netherlands B.V.
|
|
PLEGRIDY® (Peginterferon beta-1a)
|
Biogen Netherlands B.V.
|
SPINRAZA® (Nusinersen)
|
Biogen Netherlands B.V.
|
TECFIDERA® (Dimethyl fumarate)
|
Biogen Netherlands B.V. |
TYSABRI® (Natalizumab)
|
Biogen Netherlands B.V.
|
RHEUMATOLOGY
| BENEPALI™(Etanercept) |
Samsung Bioepis NL B.V. |
|
IMRALDI™ (Adalimumab)
|
Samsung Bioepis NL B.V. |
| TAVNEOS™ (Avacopan) |
Vifor Fresenius Medical Care Renal Pharma France
|
DERMATOLOGY
| IMRALDI™ (Adalimumab) |
Samsung Bioepis NL B.V. |
GASTROENTEROLOGY
| IMRALDI™ (Adalimumab) |
Samsung Bioepis NL B.V. |
NEPHROLOGY
|
KAPRUVIA® (Difelikefalin)
|
Vifor Fresenius Medical Care Renal Pharma France |
| OXLUMO® (Lumasiran) |
Alnylam Netherlands B.V. |
| TAVNEOS™ (Avacopan) |
Vifor Fresenius Medical Care Renal Pharma France |
| VELPHORO® (Sucroferric oxyhydroxide) |
Vifor Fresenius Medical Care Renal Pharma France |
LYSOSOMIC STORAGE DISEASES
| GALAFOLD® (Migalastat) |
Amicus Therapeutics Europe Limited |
RARE DISEASES
| AMVUTTRA® (Vutrisiran) |
Alnylam Netherlands B.V. |
| CRYSVITA® (Burosumab) |
Kyowa Kirin Holdings B.V. |
| GIVLAARI® (Givosiran) |
Alnylam Netherlands B.V. |
| ONPATTRO® (Patisiran) |
Alnylam Netherlands B.V. |
| OXLUMO® (Lumasiran) |
Alnylam Netherlands B.V |
| SPINRAZA® (Nusinersen) |
Biogen Netherlands B.V. |
IRON
|
FERINJECT® (Intravenous Iron
Carboxymaltose)
|
Vifor France
|
Note: The companies listed on the right column refer to the Marketing Authorisation Holder of each product